Skip to main content

Ascertaining Barriers for Compliance: policies for safe, effective and cost-effective use of medicines in Europe

Objective

Medication non-compliance is highly prevalent across all medical conditions, and represents a major barrier for realising the benefits of evidence-based therapies. The aim of the project is to produce evidence-based policy recommendations for improving patient compliance and subsequent better use of medicines by Europeans. Lack of consensus in the terminology used in this field impedes benchmarking of compliance-enhancing interventions. Therefore the first stage of the project will be to build a pan-European consensus on terminology and taxonomy of non-compliance. Effective interventions in this field should take into account the differences that exist between determinants of compliance with short-term and chronic treatments, and for different clinical sectors, health care settings and population segments. Therefore, not only will the determinants of patient compliance be identified in a systematic review of the literature, but also a survey across 16 European countries, and discrete choice experiment will be conducted. Then, a conceptual framework for the influential factors of non-compliance will be developed. Current practices of compliance management by healthcare professionals and the pharmaceutical industry will be compared across Europe, as well as educational programs from schools of medicine and pharmacy. Compliance-enhancing interventions will be compared in terms of practicality, clinical- and cost-effectiveness. The information gathered will be integrated, and priorities made to inform policy recommendations on strategies to improve patient compliance. The project findings will be discussed extensively with European experts, and based to the consensus obtained, the final recommendations will be formulated and presented to the European Commission and other relevant stakeholders. To enable widespread dissemination of the project results, they will be made available to the public as conference presentations, scientific publications and Web material.

Field of science

  • /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug
  • /humanities/languages and literature/literature - general
  • /medical and health sciences/basic medicine/pharmacology and pharmacy

Call for proposal

FP7-HEALTH-2007-B
See other projects for this call

Funding Scheme

CP-FP - Small or medium-scale focused research project

Coordinator

UNIVERSYTET MEDYCZNY W LODZI.
Address
Al. Kosciuszki, 4
90419 Lodz
Poland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 335 586
Administrative Contact
Aneta Andrzejczyk (Ms.)

Participants (5)

BANGOR UNIVERSITY
United Kingdom
EU contribution
€ 391 438
Address
College Road
LL57 2DG Bangor
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Dyfan Griffith (Mr.)
THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN

Participation ended

United Kingdom
EU contribution
€ 43 299,36
Address
King's College Regent Walk
AB24 3FX Aberdeen
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Frederick Stevenson-Robb (Mr.)
AARDEX GROUP SA
Switzerland
EU contribution
€ 351 401
Address
Avenue De La Gare 29
1950 Sion
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Bernard Vrijens (Dr.)
UNIVERSITY OF KEELE ROYAL CHARTER
United Kingdom
EU contribution
€ 806 738,64
Address
Keele University Finance Dpt
ST5 5BG Keele
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Wendy Clyne (Dr.)
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU contribution
€ 306 560
Address
Oude Markt 13
3000 Leuven
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Marion Wolpers (Ms.)